Screener
Ambarella AMBA R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Ambarella in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Ambarella’s 10-Q, filed June 2, 2026.
- Filed
- Jun 2, 2026, 2:40 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-253198
| Line item | Three Months Ended April 30, 2026 | Three Months Ended April 30, 2025 |
|---|---|---|
| Cost of revenue | 41,768 | 34,336 |
| Gross profit | 58,589 | 51,536 |
| Operating expenses: | ||
| Research and development | 58,140 | 58,819 |
| Selling, general and administrative | 19,865 | 18,575 |
| Total operating expenses | 78,005 | 77,394 |
| Loss from operations | (19,416) | (25,858) |
| Other income, net | 2,083 | 2,175 |
ITEM 1. Financial Statements
FAQ
- What is Ambarella's R&D?
- Ambarella (AMBA) reported R&D of $58.14M in Q1 2026.
- How has Ambarella's R&D changed year-over-year?
- Ambarella's R&D decreased by 1.2% year-over-year, from $58.82M to $58.14M.
- What is the long-term trend for Ambarella's R&D?
- Over 4 years (2022 to 2026), Ambarella's R&D has grown at a 9.3% compound annual growth rate (CAGR), from $167.34M to $238.52M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Ambarella's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude